The warning flags remained in a wait list for five years, with no action taken to address them. An NHS England investigation into Medway NHS Foundation Trust's ear, nose and throat service has found that clinicians and managers were aware of problems as early as 2020, yet the issue did not draw meaningful attention until March 2024, long before a backlog of 8,849 patients became public last summer.

The service, delivered at Medway Maritime Hospital in Gillingham and Darent Valley Hospital in Dartford, first flagged the scale of the problem to the Kent and Medway Integrated Care Board in May 2025. Of those affected, 4,279 patients were awaiting a first outpatient appointment and 4,570 were waiting for a follow-up, diagnostic test or procedure, with most drawn from Dartford, Gravesham, Swanley, Bexley and Greenwich. Some had waited as long as five years for care that had been assessed, at the point of referral, as routine.

What the review adds to that timeline is the more troubling part. It found no evidence that concerns raised internally, some reportedly discussed at meetings years before the backlog surfaced, were properly escalated or addressed. Reduced clinic capacity between 2019 and 2025, as staff were redirected towards urgent cancer referrals, compounded a problem that was already going unmanaged. An NHS England spokesperson described the missed opportunities to act earlier as inexcusable, which is about as blunt as institutional language gets.

The chief executive of Dartford and Gravesham NHS Trust and the temporary chief executive of Medway NHS Foundation Trust, Jonathan Wade, has issued a public apology and cited the implementation of improved monitoring and new referral management systems. In order to confirm the size of the backlog and safeguard patients who are still awaiting treatment, a cross-organizational task and finish team was established with the ICB and the regional team of NHS England. The independent inquiry that has now been revealed was independently commissioned by NHS England.

The review identified 88 patients who suffered what it classified as low harm as a result of the delays. That figure will read as a mercy to some and as thin comfort to others, given how long some of these referrals sat untouched and how easily a routine ENT case can tip into something more serious when nobody is watching the clock.

The wider significance lies less in the specific trust than in what the case exposes about how the NHS handles what it already knows. As trusts work thru inherited backlogs and try to balance administrative data with clinical realities, waiting list validation has become a live concern throughout the health service. Medway's episode suggests that in at least one service, the gap between what was known internally and what reached anyone with the authority to act was wide enough to persist for years without triggering intervention. That is a governance failing as much as an operational one, and it raises an unsettling question for other trusts operating specialities under like pressure: how many identical issues are presently languishing in someone else's waiting list software without being escalated?

For NHS England, still working through the operational consequences of its own abolition and absorption into the Department of Health and Social Care, cases like this test whether central oversight can catch what regional and trust-level structures miss. The investigation into how the Medway backlog went undiscovered will matter more for what it says about detection than for what it says about Medway itself. Local trust boards will want reassurance that the same blind spot does not exist in their own systems.

Patients, on the other hand, are left waiting for something more difficult to pass laws for than a shorter list: verification that routine logging does not, in reality, equate to forgetting.